Financial Cost Control Corporation – Trademark Portfolio
Entity Type: 03
Financial Cost Control Corporation holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ESTIMOD. The owner is based in Thousand Oaks, CA.
1678 El Cerrito Drive
Thousand Oaks, CA 91362
Showing of trademarks Trademarks
Trademark Classifications
Financial Cost Control Corporation's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Financial Cost Control Corporation have?
Financial Cost Control Corporation has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 1 cancelled.
What trademark classes does Financial Cost Control Corporation file in?
Financial Cost Control Corporation files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Financial Cost Control Corporation's most well-known trademarks?
Financial Cost Control Corporation's registered trademark portfolio includes well-known marks such as ESTIMOD. These are among 1 currently registered trademark in the portfolio.
What is Financial Cost Control Corporation's trademark registration success rate?
Financial Cost Control Corporation has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.